H

HK Inno.N Corp
KOSDAQ:195940

Watchlist Manager
HK Inno.N Corp
KOSDAQ:195940
Watchlist
Price: 35 900 KRW -1.78%
Market Cap: 1T KRW
Have any thoughts about
HK Inno.N Corp?
Write Note

HK Inno.N Corp
Net Issuance of Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

HK Inno.N Corp
Net Issuance of Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Debt CAGR 3Y CAGR 5Y CAGR 10Y
H
HK Inno.N Corp
KOSDAQ:195940
Net Issuance of Debt
-â‚©28.1B
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Net Issuance of Debt
â‚©78.4B
CAGR 3-Years
148%
CAGR 5-Years
N/A
CAGR 10-Years
9%
SK Biopharmaceuticals Co Ltd
KRX:326030
Net Issuance of Debt
-â‚©5.6B
CAGR 3-Years
62%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Net Issuance of Debt
-â‚©74B
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
-25%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Net Issuance of Debt
-â‚©8.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-3%
C
Celltrion Pharm Inc
KOSDAQ:068760
Net Issuance of Debt
-â‚©15.8B
CAGR 3-Years
-24%
CAGR 5-Years
-53%
CAGR 10-Years
N/A
No Stocks Found

HK Inno.N Corp
Glance View

Market Cap
1T KRW
Industry
Pharmaceuticals

HK inno.N Corp. engages in the provision of healthcare services. The company is headquartered in Chungju, Chungcheongbuk-Do. The company went IPO on 2021-08-09. The firm operates its business through three segments. The Prescription Drug segment is engaged in the manufacture and sale of hormone drugs, anticancer drugs, high blood pressure drugs, gastroesophageal reflux disease drugs, blood nutrient supplies, the circulatory system and others. The Health Beauty and Beverage (HB&B) segment is engaged in the manufacture and sale of products such as hangover relieving products, as well as health drinks and food products. The Other segment is engaged in the trademark royalties business and other services. The firm sells its products within domestic market and to overseas markets.

Intrinsic Value
70 395.87 KRW
Undervaluation 49%
Intrinsic Value
Price
H

See Also

What is HK Inno.N Corp's Net Issuance of Debt?
Net Issuance of Debt
-28.1B KRW

Based on the financial report for Dec 31, 2023, HK Inno.N Corp's Net Issuance of Debt amounts to -28.1B KRW.

What is HK Inno.N Corp's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 3Y
19%

Over the last year, the Net Issuance of Debt growth was 52%. The average annual Net Issuance of Debt growth rates for HK Inno.N Corp have been 19% over the past three years .

Back to Top